Post-IPO Debt - Tarsus Pharmaceuticals
Investment Firm
Overview
Tarsus Pharmaceuticals is a clinical-stage biopharmaceutical company that develops treatments for diseases with high unmet need.
Announced Date
Jan 01, 2022
Funding Type
Post Ipo Debt
Highlights
Location
United States, North America
Social
Investor Lead
N/A
Participant Investors
1
| Investor Name |
|---|
 Armentum Partners |
Round Details and Background
Tarsus Pharmaceuticals raised $175000000 on 2022-01-01 in Post-IPO Debt
Tarsus Pharmaceuticals is a clinical-stage biopharmaceutical company that develops treatments for diseases with high unmet need.
Company Funding History
7
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Aug 01, 2023 |  Post-IPO Equity - Tarsus Pharmaceuticals | - | 100.0M | |
| Jan 01, 2022 | Post-IPO Debt - Tarsus Pharmaceuticals | 1 | - | 175.0M |
| Feb 29, 2024 | Post-IPO Equity - Tarsus Pharmaceuticals | - | 100.0M | |
| Apr 19, 2024 | Post-IPO Debt - Tarsus Pharmaceuticals | 2 | - | 75.0M |
Recent Activity
There is no recent news or activity for this profile.